IRIS
FASANO, Serena
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.399
AS - Asia 1.055
NA - Nord America 918
SA - Sud America 191
AF - Africa 7
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 4.572
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 1.727
US - Stati Uniti d'America 896
IE - Irlanda 313
SG - Singapore 271
HK - Hong Kong 267
CN - Cina 224
BR - Brasile 152
VN - Vietnam 120
IT - Italia 99
GB - Regno Unito 77
KR - Corea 59
DE - Germania 34
IN - India 34
FR - Francia 31
GR - Grecia 27
SE - Svezia 26
UA - Ucraina 22
AR - Argentina 18
JP - Giappone 16
BD - Bangladesh 13
TR - Turchia 12
ES - Italia 10
PL - Polonia 10
MX - Messico 9
EC - Ecuador 7
FI - Finlandia 7
CA - Canada 6
ID - Indonesia 5
IQ - Iraq 5
MY - Malesia 4
PK - Pakistan 4
PT - Portogallo 4
VE - Venezuela 4
AT - Austria 3
NL - Olanda 3
PA - Panama 3
PY - Paraguay 3
AZ - Azerbaigian 2
BE - Belgio 2
CL - Cile 2
CO - Colombia 2
CZ - Repubblica Ceca 2
IL - Israele 2
KG - Kirghizistan 2
KZ - Kazakistan 2
SA - Arabia Saudita 2
TN - Tunisia 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BH - Bahrain 1
CR - Costa Rica 1
EU - Europa 1
GL - Groenlandia 1
JM - Giamaica 1
JO - Giordania 1
LK - Sri Lanka 1
MA - Marocco 1
NG - Nigeria 1
NI - Nicaragua 1
NP - Nepal 1
PE - Perù 1
PS - Palestinian Territory 1
RO - Romania 1
SN - Senegal 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
UY - Uruguay 1
Totale 4.572
Salva come PNG Salva come JPEG
Città #
Moscow 597
Dublin 313
Hong Kong 262
Santa Clara 183
Singapore 106
Chandler 96
Jacksonville 69
San Jose 68
Seoul 57
Ashburn 43
Ho Chi Minh City 43
Beijing 38
Hefei 36
Princeton 33
Hanoi 32
Roxbury 32
Medford 24
Bremen 20
Caserta 15
Bengaluru 13
The Dalles 13
Los Angeles 12
Cambridge 11
Des Moines 11
São Paulo 10
Da Nang 9
Dallas 9
New York 9
Haiphong 8
Jinan 8
Nanjing 8
Pamplona 8
Tokyo 8
Warsaw 8
Wilmington 8
Boardman 7
Ann Arbor 6
Chennai 6
Guangzhou 6
Naples 6
Rio de Janeiro 6
Dhaka 5
Marseille 5
Buenos Aires 4
Guayaquil 4
Mexico City 4
Milan 4
Napoli 4
Sant'Angelo in Formis 4
Shanghai 4
Villa Literno 4
Atlanta 3
Belo Horizonte 3
Biên Hòa 3
Brooklyn 3
Campinas 3
Campo Grande 3
Caracas 3
Changsha 3
Chicago 3
Columbus 3
Council Bluffs 3
Falkenstein 3
Francavilla Fontana 3
Goiânia 3
Hyderabad 3
Marília 3
Mumbai 3
Quảng Ngãi 3
Shenyang 3
Almaty 2
Aparecida de Goiânia 2
Baku 2
Betim 2
Bishkek 2
Boston 2
Brussels 2
Bắc Ninh 2
Charleston 2
Essex 2
Frankfurt am Main 2
Guarulhos 2
Gwangju 2
Hebei 2
Hillsboro 2
Huế 2
Hải Dương 2
Jiaxing 2
Johannesburg 2
Juiz de Fora 2
Kraków 2
Krasnodar 2
Kuala Lumpur 2
Lanzhou 2
Lappeenranta 2
Lisbon 2
Lucknow 2
Manaus 2
Manchester 2
Mcallen 2
Totale 2.416
Salva come PNG Salva come JPEG
Nome #
Biologic treatments for idiopathic inflammatory myopathies 189
Longterm Hydroxychloroquine Therapy and Low-dose Aspirin May Have an Additive Effectiveness in the Primary Prevention of Cardiovascular Events in Patients with Systemic Lupus Erythematosus 139
Low-dose aspirin as primary prophylaxis for cardiovascular events in systemic lupus erythematosus: A long-term retrospective cohort study 138
Cardiac involvement in undifferentiated connective tissue disease at risk for systemic sclerosis (otherwise referred to as very early-early systemic sclerosis): a TDI study 137
Anifrolumab in Refractory Systemic Lupus Erythematosus: A Real-World, Multicenter Study 125
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort 124
Low-dose aspirin as primary prophylaxis for cardiovascular events in rheumatoid arthritis: an Italian multicentre retrospective study 122
Influence of hydroxychloroquine blood levels on adhesion molecules associated with endothelial dysfunction in patients with systemic lupus erythematosus 119
Health status and concomitant prescription of immunosuppressants are risk factors for hydroxychloroquine non-adherence in systemic lupus patients with prolonged inactive disease. 116
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study—Joint and Skin (BeRLiSS-JS) 115
Precision medicine in systemic lupus erythematosus 115
Low mortality rate in Italian rheumatoid arthritis patients from a tertiary center: Putative implication of a low anti-carbamylated protein antibodies prevalence 114
Incidence of COVID-19 in an Italian cohort of patients with systemic lupus erythematosus: an observational survey 114
Biomarker panels may be superior over single molecules in prediction of renal flares in systemic lupus erythematosus: an exploratory study 112
Prevalence and factors associated with glucocorticoids (GC) use in systemic sclerosis (SSc): a systematic review and meta-analysis of cohort studies and registries 111
ILC3 in Axial Spondyloarthritis: the Gut Angle 111
The incidence of cardiovascular events in Italian patients with systemic lupus erythematosus is lower than in North European and American cohorts: Implication of disease-associated and traditional risk factors as emerged by a 16-year retrospective GIRRCS study 109
"What is fuelling the immune response in systemic lupus erythematosus?" Evaluating the key metabolites driving plasmablast differentiation 108
Autoimmune gastrointestinal complications in patients with systemic lupus erythematosus: case series and literature review 107
Clinical features of patients with systemic lupus erythematosus according to health-related quality of life, entity of pain, fatigue and depression: a cluster analysis 107
Current pharmacological treatment of idiopathic inflammatory myopathies 104
Microbiome Changes in Connective Tissue Diseases and Vasculitis: Focus on Metabolism and Inflammation 102
Bruton's Tyrosine Kinase Inhibitors: A New Therapeutic Target for the Treatment of SLE? 102
Mortality in Italian patients with rheumatoid arthritis: Evidence for a low mortality rate from cancer and infections in patients followed up at a tertiary center 102
Hydroxychloroquine daily dose, hydroxychloroquine blood levels and the risk of flares in patients with systemic lupus erythematosus 101
Early disease and low baseline damage predict response to belimumab in patients with systemic lupus erythematosus 101
Rituximab in the treatment of inflammatory myopathies: a review 97
Pathogenesis of primary Sjögren's syndrome beyond B lymphocytes 96
Lung involvement in stable undifferentiated connective tissue diseases: a rheumatology perspective 94
Systematic review and meta-analysis of cardiovascular risk in rheumatological disease: Symptomatic and non-symptomatic events in rheumatoid arthritis and systemic lupus erythematosus 94
Subclinical Pancreatitis as Onset of Systemic Lupus Erythematosus: Case Report and Review of the Literature 88
Prolonged remission is associated with a reduced risk of cardiovascular disease in patients with systemic lupus erythematosus: a GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 87
Undifferentiated connective tissue disease at risk of systemic sclerosis: A weighted score to identify patients who will evolve 85
Present and novel biologic drugs in primary Sjogren's syndrome 82
Primary prevention of cardiovascular disease in patients with systemic lupus erythematosus: case series and literature review 81
Thrombocytopenia in the Antiphospholipid Syndrome 80
The association between duration of remission, fatigue, depression and health-related quality of life in Italian patients with systemic lupus erythematosus 77
Risk factors of flare in patients with systemic lupus erythematosus after glucocorticoids withdrawal. A systematic review and meta-analysis 76
Revised European Scleroderma Trials and Research Group Activity Index is the best predictor of short-term severity accrual 75
Which patients with systemic lupus erythematosus in remission can withdraw low dose steroids? Results from a single inception cohort study 73
Systemic lupus erythematosus and the role of the GP 71
Role of the IL-23/IL-17 Pathway in Rheumatic Diseases: An Overview 71
Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus 70
Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: Results of the DeSScipher inception cohort study 68
The role of aspirin in the primary prevention of accelerated atherosclerosis in systemic autoimmune rheumatic diseases 68
Recognition and management of systemic lupus erythematosus 56
Potential involvement of IL-40 in kidney disease associated to systemic lupus erythematosus 7
Incidence and prevalence of systemic lupus erythematosus across Italian referral centers and its clinical burden in terms of disease severity, treatment and hospitalization: The ESCULAPIO study 4
Totale 4.644
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.440
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.440
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202139 0 0 0 0 0 0 0 0 0 3 35 1
2021/2022193 5 0 0 3 82 0 9 4 10 3 12 65
2022/2023485 39 3 20 14 50 29 0 23 281 1 13 12
2023/2024191 16 17 13 15 80 6 0 1 1 1 5 36
2024/2025749 1 20 4 13 99 94 91 106 63 167 65 26
2025/20262.686 91 126 146 124 257 1.594 142 61 106 39 0 0
Totale 4.644